3 YEARS IN, PROGRAM BUILDS ON CAPABILITY AND CONNECTIVITY FOR EARLY CAREER RESEARCHERS IN ENT MEDICAL DEVICES Beyond Science gives in theatre opportunities, networking with stakeholders and support from mentors
With
Professor Payal Mukherjee, Adult and Paediatric ENT Surgeon
Otologist, Cochlear Implant and Skull Base Surgeon &
Clinical Professor, Macquarie University &
TGA Advisory Committee for Medical Devices &
Clinical Associate Professor, University of Sydney &
Surgical Innovation Lead, RPA Institute of Academic Surgery &
Head of Department ENT, Sydney Adventist Hospital &
Co-Founder & Co-Director, Beyond Science
Distinguished Professor Gordon Wallace AO,
Director, Intelligent Polymer Research Institute,
University of Wollongong &
Co-Founder & Co-Director, Beyond Science
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney & Wollongong | August 2025
Surgeon-scientists and surgeon-innovators have an important role in the entire medical technology translational cycle; not only from discovery to commercialisation, but in ensuring that health technologies are implemented in value-based manner.
This includes defining safety and regulatory standards, balancing patient outcomes against health care costs, and working with policy makers to ensure that funding is both sustainable and promotes equitable access to technology.
Despite a rich history of biomedical innovation in Australia, there are limited training opportunities for surgeons to develop these skills. Within NSW, there are no formal surgeon-scientist training pathways in Otolaryngology, Head and Neck Surgery.
In 2022, Distinguished Professor Gordon Wallace AO and Professor Mukherjee jointly established Beyond Science as a clinician led, academically supported and clinician run Australian-first medical technology translation program.
The program is aimed at early career researchers and clinician-scientists working in medical device research specifically in otolaryngology (ear, nose, and throat), head and neck surgery.
Its core mission is to build capability and foster connections between researchers and key stakeholders such as industry, government, universities, and health systems.
This is through helping researchers understand health system priorities and translation pathways from research to real-world impact. Uniquely, this includes opportunity to enter surgical environments for observation and tissue collection.
Australian Health Journal spoke to its founders about how it supports academic mentorship and creates networking opportunities to help early career stage medical device researchers connect with clinicians, policymakers, industry leaders, and funding bodies.
Beyond Science is funded by Passe & Williams Foundation & the Sydney Local Health District
Source: Adapted from Beyond Science, RACS and University of Wollongong websites
You Might also like
- 
					
					Lasers in dental treatment without needles and drillsIn 2017, Dr. Omar Zuaiter and Alaa Habeb launched Dentroid, a dental technology startup with a mission to make dentistry a kinder and friendlier experience for patients and dentists using photonics (using laser technology) and robotics, as alternatives to needles, drills and sprays. The vision for the startup is to have dentistry adopt laser technology, addressing the root causes of dental pain & anxiety, and create a pain-free dental experience. 
- 
					
					Family biz succeeds in vaccine approval & distributionIt’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia. In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations. 
- 
					
					Interventional radiologists offer alternative to hysterectomyIn Australia in the last five years, an estimated 6066 women per year have undergone hysterectomies to treat fibroid-related diseases, while just 145 women each year have undergone a uterine artery embolisation, or UAE. The procedure can effectively treat the majority of bleeding uterine fibroids. Each year, thousands of Australian women undergo invasive and life-altering hysterectomies to treat debilitating pain and blood loss caused by uterine fibroids. But there’s another option: a minimally invasive, pin-hole procedure that treats the symptoms, yet leaves the uterus intact. 
 
		
		 
					
																				
					 
					
																				
					